FMAC's $159M SPAC Faces Nasdaq Delisting Over Late 10-Q Filing

For SPAC arbitrage and event-driven investors, a Nasdaq deficiency notice is a liquidity and governance event, not merely a filing technicality. FMAC's $159M capitalization is aspirational — zero revenue and a P/E of 672.67x reflect acquisition optionality rather than current earnings — so the exchange's decision on the Nov. 23 plan will determine whether shareholders retain listed liquidity into 2027. Regulatory overhangs like this can compress SPAC spreads and shift redemption economics.

On September 25, 2026, Future Money Acquisition Corp (Nasdaq: FMAC) disclosed that it had received a Nasdaq Listing Qualifications Department deficiency notice because it did not file its Form 10-Q for the fiscal quarter ended July 31, 2026 by the required deadline. Both GuruFocus and Seeking Alpha reported the announcement on the same day. Under Nasdaq Listing Rule 5250(c)(2), listed companies must file all required periodic financial reports with the Securities and Exchange Commission on a timely basis, and a missed 10-Q triggers a formal compliance process. FMAC now has until November 23, 2026 to submit a plan to regain compliance. If Nasdaq accepts that plan, the exchange can grant an extension until March 22, 2027 for the late quarterly report. If no plan is accepted or the report remains unfiled, Nasdaq may initiate delisting proceedings, which would move FMAC from a national exchange to over-the-counter trading.

“

FMAC's $159M capitalization is aspirational — zero revenue and a P/E of 672.67x reflect acquisition optionality rather than current earnings — so the exchange's decision on the Nov.

The notice is especially significant because FMAC is not an operating business. It is a special purpose acquisition company, or SPAC, a blank-check vehicle that raised capital through an initial public offering to acquire or merge with a private operating company. The company generates no revenue and does not run commercial operations, so its financial statements are dominated by trust account assets, cash, accruals, and complex warrant and liability accounting rather than traditional top-line growth. GuruFocus noted that FMAC's market capitalization is approximately $159 million, its price-to-sales ratio is effectively zero because revenue is zero, and its price-to-earnings ratio of 672.67 times is not a meaningful valuation metric. The market price therefore reflects expectations for future acquisition success and sponsor credibility, not current financial performance.

For investors in SPACs and exchange-listed shells, a missed 10-Q filing has outsized consequences. The Nasdaq listing is one of the main institutional attributes of a SPAC: it supports daily liquidity in shares, units, and warrants, and it gives eventual merger targets confidence that the SPAC currency is tradeable. A delisting would shrink the pool of eligible buyers, widen bid-ask spreads, and possibly impair the company's ability to consummate a business combination on attractive terms. Even if an extension is granted, the deficiency notice signals potential weaknesses in internal financial reporting, audit readiness, or governance. For a vehicle with no operating cash flows, market value rests almost entirely on the credibility of its sponsor and the probability of a successful acquisition; regulatory slippage erodes that credibility.